NEW YORK (GenomeWeb News) – Horizon Discovery said today that the National Institutes of Health Center for Regenerative Medicine will use its genome editing technology in disease studies to discover how specific genes affect stem cells.

Under the technology access agreement, NIH CRM will use Horizon's Genesis technology to engineer stem cells to create isogenic disease models with specific induced mutations and lineage markers to understand the effects certain genes have on stem cells as they differentiate.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.